A Role for Nanoparticles in Treating Traumatic Brain Injury
Traumatic brain injury (TBI) is one of the main causes of disability in children and young adults, as well as a significant concern for elderly individuals. Depending on the severity, TBI can have a long-term impact on the quality of life for survivors of all ages. The primary brain injury can resul...
Main Authors: | Badrul Alam Bony, Forrest M. Kievit |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/9/473 |
Similar Items
-
Racial and Ethnic Inequities in Mortality During Hospitalization for Traumatic Brain Injury: A Call to Action
by: Emma A. Richie, et al.
Published: (2021-06-01) -
Blood?Brain Barrier Breakdown and Astrocyte Reactivity Evident in the Absence of Behavioral Changes after Repeated Traumatic Brain Injury
by: Celeste Dunn, et al.
Published: (2021-08-01) -
The Nanotheranostic Researcher’s Guide for Use of Animal Models of Traumatic Brain Injury
by: Brandon Z. McDonald, et al.
Published: (2021-12-01) -
Optimal Timing of External Ventricular Drainage after Severe Traumatic Brain Injury: A Systematic Review
by: Charlene Y. C. Chau, et al.
Published: (2020-06-01) -
Intranasal Leukemia Inhibitory Factor Attenuates Gliosis and Axonal Injury and Improves Sensorimotor Function After a Mild Pediatric Traumatic Brain Injury
by: Veera D'Mello, et al.
Published: (2023-04-01)